Search Results - "de Ligny, B. Hurault"

Long‐Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype by Pallet, N., Etienne, I., Buchler, M., Bailly, E., Hurault de Ligny, B., Choukroun, G., Colosio, C., Thierry, A., Vigneau, C., Moulin, B., Le Meur, Y., Heng, A.‐E., Legendre, C., Beaune, P., Loriot, M. A., Thervet, E.

“…Pretransplantation adaptation of the daily dose of tacrolimus to CYP3A5 genotype is associated with improved achievement of target trough concentration (C0),…”
Get full text

Predictive Modeling of Tacrolimus Dose Requirement Based on High‐Throughput Genetic Screening by Damon, C., Luck, M., Toullec, L., Etienne, I., Buchler, M., Hurault de Ligny, B., Choukroun, G., Thierry, A., Vigneau, C., Moulin, B., Heng, A.‐E., Subra, J.‐F., Legendre, C., Monnot, A., Yartseva, A., Bateson, M., Laurent‐Puig, P., Anglicheau, D., Beaune, P., Loriot, M. A., Thervet, E., Pallet, N.

“…Any biochemical reaction underlying drug metabolism depends on individual gene–drug interactions and on groups of genes interacting together. Based on a…”
Get full text

Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study by Lebranchu, Y., Thierry, A., Toupance, O., Westeel, P. F., Etienne, I., Thervet, E., Moulin, B., Frouget, T., Le Meur, Y., Glotz, D., Heng, A‐E., Onno, C., Buchler, M., Girardot‐Seguin, S., De Ligny, B. Hurault

“…Sirolimus (SRL) allows to minimize the use of cyclosporine (CsA), but de novo administration after transplantation is associated with various complications. We…”
Get full text

Safety and Long‐Term Efficacy of Eculizumab in a Renal Transplant Patient with Recurrent Atypical Hemolytic–Uremic Syndrome by Chatelet, V., Frémeaux‐Bacchi, V., Lobbedez, T., Ficheux, M., Hurault de Ligny, B.

Get full text

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF—Four‐Year Results of the Postconcept Study by Lebranchu, Y., Thierry, A., Thervet, E., Büchler, M., Etienne, I., Westeel, P. F., de Ligny, B. Hurault, Moulin, B., Rérolle, J. P., Frouget, T., Girardot‐Seguin, S., Toupance, O.

“…Calcineurin inhibitor (CNI) withdrawal has been used as a strategy to improve renal allograft function. We previously reported that conversion from…”
Get full text

Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6‐Month Course of Steroids by Büchler, M., Caillard, S., Barbier, S., Thervet, E., Toupance, O., Mazouz, H., Hurault de Ligny, B., Le Meur, Y., Thierry, A., Villemain, F., Heng, A.‐E., Moulin, B., Morin, M. P., Noël, C., Lebranchu, Y.

“…To evaluate the efficacy and tolerance of a calcineurin inhibitor (CNI)‐free regimen, 145 renal recipients were prospectively randomized to receive either…”
Get full text

Five‐Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study by Lebranchu, Y., Snanoudj, R., Toupance, O., Weestel, P.‐F., de Ligny, B. Hurault, Buchler, M., Rerolle, J.‐P., Thierry, A., Moulin, B., Subra, J.‐F., Deteix, P., Pogamp, P. Le, Finzi, L., Etienne, I.

“…Calcineurin inhibitors improve acute rejection rates and short‐term graft survival in renal transplantation, but their continuous use may be deleterious. We…”
Get full text

Eculizumab: Safety and Efficacy After 17 Months of Treatment in a Renal Transplant Patient With Recurrent Atypical Hemolytic-Uremic Syndrome: Case Report by Châtelet, V, Lobbedez, T, Frémeaux-Bacchi, V, Ficheux, M, Ryckelynck, J.Ph, Hurault de Ligny, B

“…Abstract In a recent study, eculizumab, a humanized monoclonal antibody which targets complement factor C5, appeared to resolve hemolysis and thrombocytopenia…”
Get full text

Severe cryptococcal‐associated neurological immune reconstitution inflammatory syndrome in a renal transplant recipient treated with adalimumab by Deshayes, S., Bouvier, N., Chatelet, V., Hurault de Ligny, B., Dargère, S., Bonhomme, J., Béchade, C.

“…Cryptococcosis is a major concern in organ transplant recipients. A decrease in immunosuppressants following the initiation of antifungal therapy is currently…”
Get full text

Complicated Lymphoceles After Kidney Transplantation by Zagdoun, E, Ficheux, M, Lobbedez, T, Chatelet, V, Thuillier-Lecouf, A, Bensadoun, H, Ryckelynck, J.-P, Hurault de Ligny, B

“…Abstract Lymphocele is a common surgical complication after renal transplantation. The incidence of lymphocele ranges from 0.6% to 18%. The aim of this study…”
Get full text

Fumagillin‐induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis by Audemard, A., Le Bellec, M.L., Carluer, L., Dargère, S., Verdon, R., Castrale, C., Lobbedez, T., Hurault de Ligny, B.

“…Microsporidiosis is an opportunistic infection in organ transplant recipients and patients with other cellular immunodeficiency. Fumagillin is an effective…”
Get full text

The Influence of Cytomegalovirus Infections on Patient and Renal Graft Outcome: A 3-year, Multicenter, Observational Study (Post-ECTAZ Study) by Abou-Ayache, R, Büchler, M, Le Pogamp, P, Westeel, P.-F, Le Meur, Y, Etienne, I, Hurault de Ligny, B, Toupance, O, Caillard, S, Sinnasse-Raymond, G, Touchard, G

“…Abstract Cytomegalovirus (CMV) infections posttransplant may increase the risk of acute rejection, graft failure, patient death, opportunistic infections,…”
Get full text

Cyclosporine Monitoring in Peripheral Blood Mononuclear Cells: Feasibility and Interest. A Prospective Study on 20 Renal Transplant Recipients by Lepage, J.M, Lelong-Boulouard, V, Lecouf, A, Debruyne, D, de Ligny, B. Hurault, Coquerel, A

“…Abstract Cyclosporine (CsA) has potent immunosuppressive properties, reflecting its ability to block the transcription of cytokine genes (mainly interleukin 2)…”
Get full text

Long-Term Results of Monoclonal Anti-Il2-Receptor Antibody Versus Polyclonal Antilymphocyte Antibodies as Induction Therapy in Renal Transplantation by Al Najjar, A., Etienne, I., Le Pogamp, P., Bridoux, F., Le Meur, Y., Toupance, O., Mousson, C., Caillard, S., de Ligny, B. Hurault, Marlière, J.F., Lebranchu, Y.

“…We compared the influence of induction therapy on 5-year patient and graft survival as well as on renal function in 100 kidney graft recipients at low…”
Get full text

The Evolution of Weight and Body Composition in Renal Transplant Recipients: Two-Year Longitudinal Study by El Haggan, W., Hurault de Ligny, B., Partiu, A., Sabatier, J.P., Lobbedez, T., Levaltier, B., Ryckelynck, J.P.

“…Previous series have reported weight gain after kidney transplantation. However few studies have investigated the body composition after kidney…”
Get full text

Interstitial Fibrosis Quantification in Renal Transplant Recipients Randomized to Continue Cyclosporine or Convert to Sirolimus by Servais, A., Meas‐Yedid, V., Toupance, O., Lebranchu, Y., Thierry, A., Moulin, B., Etienne, I., Presne, C., Hurault, De Ligny B., Le Pogamp, P., Le Meur, Y., Glotz, D., Hayem, C., Marin, J. C. Olivo, Thervet, E.

“…Conversion from cyclosporine (CsA) to sirolimus at week 12 after kidney transplantation is associated with a significant improvement in renal function. The aim…”
Get full text

Renal lymphangiectasia, a rare case of perirenal infiltration by Parazols, F, Fournier, L, Bouvier, N, Pelage, J-P, Lobbedez, T, Hurault de Ligny, B

“…Renal lymphangiectasia is a bilateral cystic infiltration of the perirenal and parapelvic space which is caused by the obstruction of the renal lymphatic…”
Get full text

MP-06.04 Management of Localized Prostate Cancer by Retropubic Radical Prostatectomy in Kidney Recipients by Doerfler, A, Fumey, J, Hurault De Ligny, B, LeToquin-Bernard, S, Le Gal, S, Bensadoun, H

Get full text

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder : A retrospective analysis on 32 patients by MILPIED, N, VASSEUR, B, REGUERRE, Y, STOPPA, A. M, BOURQUARD, P, HURAULT DE LIGNY, B, DUBIEF, F, MATHIEU-BOUE, A, LEBLOND, V, PARQUET, N, GARNIER, J. L, ANTOINE, C, QUARTIER, P, CARRET, A. S, BOUSCARY, D, FAYE, A, BOURBIGOT, B

“…B-lymphoproliferative post-transplant disorder (BLPD) is a severe complication of organ and bone marrow transplantation. The reduction of immuno-suppressive…”
Get full text

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients by Milpied, N., Vasseur, B., Parquet, N., Garnier, J. L., Antoine, C., Quartier, P., Carret, A. S., Bouscary, D., Faye, A., Bourbigot, B., Reguerre, Y., Stoppa, A. M., Bourquard, P., de Ligny, B. Hurault, Dubief, F., Mathieu-Boue, A., Leblond, V.

“…Background: B-lymphoproliferative post-transplant disorder (BLPD) is a severe complication of organ and bone marrow transplantation. The reduction of…”
Get full text